Business Description
Vycor Medical Inc
NAICS : 339112
SIC : 3841
ISIN : US92921M2035
Total Employee Number:
7Description
Vycor Medical Inc provides the medical community with superior surgical and therapeutic solutions and operates two distinct business units within the medical device industry. Vycor Medical designs, develops and markets medical devices for use in neurosurgery. NovaVision provides non-invasive rehabilitation therapies for those who have vision disorders resulting from neurological brain damage such as that caused by a stroke. The company operates in two segments, Vycor Medical and NovaVision, with the majority of the revenue been derived from Vycor Medical segment.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.18 | |||||
Equity-to-Asset | -4.95 | |||||
Debt-to-Equity | -0.23 | |||||
Debt-to-EBITDA | 6.37 | |||||
Interest Coverage | 0.89 | |||||
Piotroski F-Score | 7/9 | |||||
Altman Z-Score | -58.6 | |||||
Beneish M-Score | -3.46 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 12.8 | |||||
3-Year FCF Growth Rate | 47.7 | |||||
3-Year Book Growth Rate | -10.7 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 66.74 | |||||
9-Day RSI | 60.52 | |||||
14-Day RSI | 56.17 | |||||
3-1 Month Momentum % | -5.64 | |||||
6-1 Month Momentum % | -45.03 | |||||
12-1 Month Momentum % | -34.04 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 0.13 | |||||
Quick Ratio | 0.09 | |||||
Cash Ratio | 0.04 | |||||
Days Inventory | 198.45 | |||||
Days Sales Outstanding | 45.33 | |||||
Days Payable | 128.28 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -0.9 | |||||
Shareholder Yield % | 2.11 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 83.62 | |||||
Operating Margin % | 4.88 | |||||
Net Margin % | -0.74 | |||||
EBITDA Margin % | 8.17 | |||||
FCF Margin % | 5.99 | |||||
OCF Margin % | 5.99 | |||||
ROA % | -1.57 | |||||
ROIC % | 8.05 | |||||
3-Year ROIIC % | -695.92 | |||||
ROC (Joel Greenblatt) % | 42.75 | |||||
Moat Score | 2 | |||||
Tariff Resilience Score | 5 |
GF Value Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | N/A |
N/A
|
N/A
| |||
PE Ratio without NRI | N/A |
N/A
|
N/A
| |||
Price-to-Owner-Earnings | 34.5 | |||||
PS Ratio | 1.28 | |||||
Price-to-Free-Cash-Flow | 23 | |||||
Price-to-Operating-Cash-Flow | 23 | |||||
EV-to-EBIT | 33.8 | |||||
EV-to-EBITDA | 20.19 | |||||
EV-to-Revenue | 1.65 | |||||
EV-to-FCF | 27.52 | |||||
Price-to-GF-Value | 0.58 | |||||
Price-to-Median-PS-Value | 0.53 | |||||
Earnings Yield (Greenblatt) % | 2.96 | |||||
FCF Yield % | 4.91 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:VYCO
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Vycor Medical Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 1.886 | ||
| EPS (TTM) ($) | - | ||
| Beta | 0.1782 | ||
| 3-Year Sharpe Ratio | 0.09 | ||
| 3-Year Sortino Ratio | 0.17 | ||
| Volatility % | 61.69 | ||
| 14-Day RSI | 56.17 | ||
| 14-Day ATR ($) | 0.002114 | ||
| 20-Day SMA ($) | 0.065797 | ||
| 12-1 Month Momentum % | -34.04 | ||
| 52-Week Range ($) | 0.0321 - 0.2 | ||
| Shares Outstanding (Mil) | 33.37 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 7 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Vycor Medical Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Vycor Medical Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| 0.006667:1 Stock Split | 2013-01-15 | 1.35 (+0.00%) |
Show
Entries
Vycor Medical Inc Frequently Asked Questions
What is Vycor Medical Inc(VYCO)'s stock price today?
The current price of VYCO is $0.07. The 52 week high of VYCO is $0.20 and 52 week low is $0.03.
When is next earnings date of Vycor Medical Inc(VYCO)?
The next earnings date of Vycor Medical Inc(VYCO) is .
Does Vycor Medical Inc(VYCO) pay dividends? If so, how much?
Vycor Medical Inc(VYCO) does not pay dividend.
Guru Commentaries on OTCPK:VYCO
No articles.
Press Release
| Subject | Date | ||
|---|---|---|---|
| Vycor Medical Reports Financial Results for the Year Ended December 31st, 2017 | 2019-04-11 | ||
| Vycor Medical Reports Financial Results for the Year Ended December 31st, 2018 | 2019-04-11 |
Articles on Vycor Medical Inc
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers